Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps with early hair regrowth in people with alopecia areata.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

New molecules can prevent cell death in hair follicles.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Indinavir therapy can cause reversible skin, hair, and nail darkening.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

A substance called compound-1 could help increase hair growth by maintaining prostaglandin levels in hair follicles.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Baricitinib successfully treated severe hair loss.

Finasteride helps female-pattern hair loss.

The essential oils from Hedyotis corymbosa, Inula racemose, and Holostemma adakodien have significant antibacterial and antifungal properties.